Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Ferrante

Showing results (281-290 of 350) with videos related to

Pageof 35
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 14, 2014
A panel to predict long-term outcome of infliximab therapy for patients with ulcerative colitisMaria Theresa Arias, Niels Vande Casteele, Séverine Vermeire, et al.
Journal of Crohn'S & Colitis|November 5, 2013
European evidence based consensus for endoscopy in inflammatory bowel diseaseVito Annese, Marco Daperno, Matthew D Rutter, et al.
Gastroenterology|September 8, 2019
Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Ulcerative ColitisWilliam J Sandborn, Marc Ferrante, Bal R Bhandari, et al.
Journal of Crohn'S & Colitis|June 2, 2021
Long-Term Safety and Efficacy of Risankizumab Treatment in Patients with Crohn's Disease: Results from the Phase 2 Open-Label Extension StudyMarc Ferrante, Brian G Feagan, Julián Panés, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 20, 2020
Efficacy and Safety of Continued Treatment With Mirikizumab in a Phase 2 Trial of Patients With Ulcerative ColitisWilliam J Sandborn, Marc Ferrante, Bal R Bhandari, et al.
Journal of Crohn'S & Colitis|October 4, 2018
Outcome of Pregnancies in Female Patients With Inflammatory Bowel Diseases Treated With VedolizumabAnnick Moens, Karen van Hoeve, Evelien Humblet, et al.
Plos One|December 30, 2014
Integrated miRNA and mRNA expression profiling in inflamed colon of patients with ulcerative colitisJan Van der Goten, Wiebe Vanhove, Katleen Lemaire, et al.
Journal of Crohn'S & Colitis|April 26, 2020
Early Postoperative Endoscopic Recurrence in Crohn's Disease Is Characterised by Distinct Microbiota RecolonisationKathleen Machiels, Marta Pozuelo Del Río, Adrian Martinez-De la Torre, et al.
European Journal of Gastroenterology & Hepatology|April 14, 2020
The prevention and management of Crohn's disease postoperative recurrence: results from the Y-ECCO/ClinCom 2019 SurveyGabriele Dragoni, Nik Ding, Krisztina B Gecse, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 29, 2014
Withdrawal of immunomodulators after co-treatment does not reduce trough level of infliximab in patients with Crohn's diseaseDavid Drobne, Peter Bossuyt, Christine Breynaert, et al.
Pageof 35

Showing results (281-290 of 350) with videos related to

Sort By:
Pageof 35
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 14, 2014
A panel to predict long-term outcome of infliximab therapy for patients with ulcerative colitisMaria Theresa Arias, Niels Vande Casteele, Séverine Vermeire, et al.
Journal of Crohn'S & Colitis|November 5, 2013
European evidence based consensus for endoscopy in inflammatory bowel diseaseVito Annese, Marco Daperno, Matthew D Rutter, et al.
Gastroenterology|September 8, 2019
Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Ulcerative ColitisWilliam J Sandborn, Marc Ferrante, Bal R Bhandari, et al.
Journal of Crohn'S & Colitis|June 2, 2021
Long-Term Safety and Efficacy of Risankizumab Treatment in Patients with Crohn's Disease: Results from the Phase 2 Open-Label Extension StudyMarc Ferrante, Brian G Feagan, Julián Panés, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 20, 2020
Efficacy and Safety of Continued Treatment With Mirikizumab in a Phase 2 Trial of Patients With Ulcerative ColitisWilliam J Sandborn, Marc Ferrante, Bal R Bhandari, et al.
Journal of Crohn'S & Colitis|October 4, 2018
Outcome of Pregnancies in Female Patients With Inflammatory Bowel Diseases Treated With VedolizumabAnnick Moens, Karen van Hoeve, Evelien Humblet, et al.
Plos One|December 30, 2014
Integrated miRNA and mRNA expression profiling in inflamed colon of patients with ulcerative colitisJan Van der Goten, Wiebe Vanhove, Katleen Lemaire, et al.
Journal of Crohn'S & Colitis|April 26, 2020
Early Postoperative Endoscopic Recurrence in Crohn's Disease Is Characterised by Distinct Microbiota RecolonisationKathleen Machiels, Marta Pozuelo Del Río, Adrian Martinez-De la Torre, et al.
European Journal of Gastroenterology & Hepatology|April 14, 2020
The prevention and management of Crohn's disease postoperative recurrence: results from the Y-ECCO/ClinCom 2019 SurveyGabriele Dragoni, Nik Ding, Krisztina B Gecse, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 29, 2014
Withdrawal of immunomodulators after co-treatment does not reduce trough level of infliximab in patients with Crohn's diseaseDavid Drobne, Peter Bossuyt, Christine Breynaert, et al.
Pageof 35